Open AccessDexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review
Author(s) -
Kamal Kishore,
Pooja Bhat,
Pradeep Venkatesh,
Cecilia C. Canizela
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s209395
Subject(s) - medicine , macular edema , implant , dexamethasone , ophthalmology , intraocular pressure , uveitis , retinal vein , central retinal vein occlusion , diabetic macular edema , diabetic retinopathy , retinal , surgery , diabetes mellitus , endocrinology
The purpose of this review article is to provide a comprehensive review of the current applications of intravitreal DEX implant (Ozurdex ® , Allergan Inc, Irvine, CA) for a variety of ophthalmic conditions - ranging from FDA approved indications to off-label uses. We have attempted to provide relevant evidence from the literature to help a reader develop an understanding of the biological and pharmacokinetic properties of DEX implant, its uses, and potential side effects.